Literature DB >> 24951757

MicroRNA-management of lipoprotein homeostasis.

Xinghui Sun1, Mark W Feinberg2.   

Abstract

Entities:  

Keywords:  Editorials; HDL cholesterol lipoproteins; VLDL cholesterol; cardiovascular diseases; miR-33, human

Mesh：

Substances：

Year:  2014        PMID： 24951757      PMCID： PMC4083235          DOI： 10.1161/CIRCRESAHA.114.304228

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  42 in total

Review 1.  A big role for small RNAs in HDL homeostasis.

Authors:  Mireille Ouimet; Kathryn J Moore
Journal:  J Lipid Res       Date:  2013-03-18       Impact factor: 5.922

2.  A regulatory role for microRNA 33* in controlling lipid metabolism gene expression.

Authors:  Leigh Goedeke; Frances M Vales-Lara; Michael Fenstermaker; Daniel Cirera-Salinas; Aranzazu Chamorro-Jorganes; Cristina M Ramírez; Julie A Mattison; Rafael de Cabo; Yajaira Suárez; Carlos Fernández-Hernando
Journal:  Mol Cell Biol       Date:  2013-04-01       Impact factor: 4.272

3.  Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia.

Authors:  Wu Yin; Ester Carballo-Jane; David G McLaren; Vivienne H Mendoza; Karen Gagen; Neil S Geoghagen; Lesley Ann McNamara; Judith N Gorski; George J Eiermann; Aleksandr Petrov; Michael Wolff; Xinchun Tong; Larissa C Wilsie; Taro E Akiyama; Jing Chen; Anil Thankappan; Jiyan Xue; Xiaoli Ping; Genevieve Andrews; L Alexandra Wickham; Cesaire L Gai; Tu Trinh; Alison A Kulick; Marcie J Donnelly; Gregory O Voronin; Ray Rosa; Anne-Marie Cumiskey; Kavitha Bekkari; Lyndon J Mitnaul; Oscar Puig; Fabian Chen; Richard Raubertas; Peggy H Wong; Barbara C Hansen; Ken S Koblan; Thomas P Roddy; Brian K Hubbard; Alison M Strack
Journal:  J Lipid Res       Date:  2011-10-23       Impact factor: 5.922

Review 4.  Familial hypercholesterolemia and coronary heart disease: a HuGE association review.

Authors:  Melissa A Austin; Carolyn M Hutter; Ron L Zimmern; Steve E Humphries
Journal:  Am J Epidemiol       Date:  2004-09-01       Impact factor: 4.897

5.  MicroRNA 33 regulates glucose metabolism.

Authors:  Cristina M Ramírez; Leigh Goedeke; Noemi Rotllan; Je-Hyun Yoon; Daniel Cirera-Salinas; Julie A Mattison; Yajaira Suárez; Rafael de Cabo; Myriam Gorospe; Carlos Fernández-Hernando
Journal:  Mol Cell Biol       Date:  2013-05-28       Impact factor: 4.272

6.  Therapeutic silencing of microRNA-33 inhibits the progression of atherosclerosis in Ldlr-/- mice--brief report.

Authors:  Noemi Rotllan; Cristina M Ramírez; Binod Aryal; Christine C Esau; Carlos Fernández-Hernando
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-05-23       Impact factor: 8.311

7.  Anti-miR-33 therapy does not alter the progression of atherosclerosis in low-density lipoprotein receptor-deficient mice.

Authors:  Tyler J Marquart; Judy Wu; Aldons J Lusis; Ángel Baldán
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-03       Impact factor: 8.311

8.  Anti-atherosclerosis or No Anti-atherosclerosis: That is the miR-33 question.

Authors:  Anders M Näär
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-03       Impact factor: 8.311

9.  Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study.

Authors:  Marina Cuchel; Emma A Meagher; Hendrik du Toit Theron; Dirk J Blom; A David Marais; Robert A Hegele; Maurizio R Averna; Cesare R Sirtori; Prediman K Shah; Daniel Gaudet; Claudia Stefanutti; Giovanni B Vigna; Anna M E Du Plessis; Kathleen J Propert; William J Sasiela; LeAnne T Bloedon; Daniel J Rader
Journal:  Lancet       Date:  2012-11-02       Impact factor: 79.321

10.  MicroRNA-33 deficiency reduces the progression of atherosclerotic plaque in ApoE-/- mice.

Authors:  Takahiro Horie; Osamu Baba; Yasuhide Kuwabara; Yoshimasa Chujo; Shin Watanabe; Minako Kinoshita; Masahito Horiguchi; Tomoyuki Nakamura; Kazuhisa Chonabayashi; Masakatsu Hishizawa; Koji Hasegawa; Noriaki Kume; Masayuki Yokode; Toru Kita; Takeshi Kimura; Koh Ono
Journal:  J Am Heart Assoc       Date:  2012-12-19       Impact factor: 5.501
View more
  7 in total

Review 1.  High-Density Lipoprotein Function in Cardiovascular Disease and Diabetes Mellitus.

Authors:  Yi He; Vishal Kothari; Karin E Bornfeldt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-02       Impact factor: 8.311

Review 2.  MicroRNAs 33, 122, and 208: a potential novel targets in the treatment of obesity, diabetes, and heart-related diseases.

Authors:  Osama Abo Alrob; Said Khatib; Saleh A Naser
Journal:  J Physiol Biochem       Date:  2016-12-14       Impact factor: 4.158

Review 3.  miRNAs in atherosclerotic plaque initiation, progression, and rupture.

Authors:  Ioannis Andreou; Xinghui Sun; Peter H Stone; Elazer R Edelman; Mark W Feinberg
Journal:  Trends Mol Med       Date:  2015-03-11       Impact factor: 11.951

4.  miRNA Targeting of Oxysterol-Binding Protein-Like 6 Regulates Cholesterol Trafficking and Efflux.

Authors:  Mireille Ouimet; Elizabeth J Hennessy; Coen van Solingen; Graeme J Koelwyn; Maryem A Hussein; Bhama Ramkhelawon; Katey J Rayner; Ryan E Temel; Ljubica Perisic; Ulf Hedin; Lars Maegdefessel; Michael J Garabedian; Lesca M Holdt; Daniel Teupser; Kathryn J Moore
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-03-03       Impact factor: 8.311

5.  Expression profiling of preadipocyte microRNAs by deep sequencing on chicken lines divergently selected for abdominal fatness.

Authors:  Weishi Wang; Zhi-Qiang Du; Bohan Cheng; Yuxiang Wang; Jing Yao; Yumao Li; Zhiping Cao; Peng Luan; Ning Wang; Hui Li
Journal:  PLoS One       Date:  2015-02-12       Impact factor: 3.240

Review 6.  MicroRNAs as Regulators of Cancer Cell Energy Metabolism.

Authors:  Natarajaseenivasan Suriya Muthukumaran; Prema Velusamy; Charles Solomon Akino Mercy; Dianne Langford; Kalimuthusamy Natarajaseenivasan; Santhanam Shanmughapriya
Journal:  J Pers Med       Date:  2022-08-18

Review 7.  Emerging role of microRNAs in lipid metabolism.

Authors:  Zhihong Yang; Tyler Cappello; Li Wang
Journal:  Acta Pharm Sin B       Date:  2015-02-24       Impact factor: 11.413
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.